Research highlights
Public health
First hepatitis E outbreak in Southeastern Senegal
Endemic circulation of HEV could be favoured by precarious living conditions including lack of hygie...
Clinical feature
Treatment
An unusual case of severe hepatitis E in a healthy young patient treated with ribavirin
Hepatitis E is a rising cause of acute hepatitis in developed nations. Most cases result in a mild a...
Prevention
Public health
Fulminant Transfusion-Associated HEV Infection Despite Screening, England, 2016-2020
HEV and Blood Donation
Hepatitis E virus (HEV) infections can have severe, even fatal implication...
Clinical feature
Public health
HEV infection among pregnant women in central Nigeria
HEV infection may be life-threatening in pregnant women and has been linked with 20–30% mortality,...
Experimental model
Modelling chronic HEV infection in rats
Convenient small animal models of chronic hepatitis E are necessary for investigating the course of ...
Public health
A meticulous characterization of HEV infection in the United States
The hepatitis E virus (HEV) is an emergent causative agent of acute hepatitis worldwide, transmitted...
Animal reservoir
One health
HEV infection dynamics within Dutch pig farms – no ‘one size fits all’
Hepatitis E virus (HEV) genotype 3 is very common in pig farms throughout the world and pigs are an ...
Popular
Public health
Introducing a Chinese consortium of hepatitis E
CCSHE, The Chinese Consortium for the Study of Hepatitis E, is an academic association dedicated to ...
One health
Rat HEV: a story by Dr. Siddharth Sridhar
Hepatitis E has always fascinated me. Epidemiologically, this virus is a shape-shifter, infecting hu...
Public health
A decade of HEV molecular surveillance in Germany, 2010–2019
Orthohepevirus A, also known as the hepatitis E virus (HEV), is endemic in Europe. HEV is divided in...
Public health
Hepatitis E Outbreaks among refugees and internally displaced persons in sub-Saharan Africa
It is often challenging to obtain the most up-to-date burden of infectious diseases among refugees...
Diagnostics
Exosome-derived CPS1 for the diagnosis and prognosis of HEV-ALF
Although hepatitis E virus (HEV) infection is usually asymptomatic and results in a self-limited dis...
Virology
The impact of ribavirin-induced HEV ORF2 single-nucleotide variants
Hepatitis E virus (HEV) has increasing prevalence worldwide with over three million infections every...
Virology
HEV, a master of genetic information condensation
HEV genome expresses three open reading frames (ORFs): ORF1, ORF2 and ORF3. ORF1 encodes the ORF1 no...
News
Antiviral agent
PhD awarded to Yunlong Li on hepatitis E research
On 30 August, Yunlong Li defended his PhD thesis on the development of antiviral therapy for treatin...
Public health
Experience of the first HEV vaccination campaign
Hepatitis E outbreaks regularly occur during humanitarian emergencies, often leading to tens of thou...
Public health
Introducing a Chinese consortium of hepatitis E
CCSHE, The Chinese Consortium for the Study of Hepatitis E, is an academic association dedicated to ...
Clinical feature
Advancing chronic hepatitis E research and patient care
The hepatitis E virus (HEV) was initially thought to exclusively cause acute hepatitis. However, the...
Public health
Severe hepatitis in children of unknown origin – update in Journal of Hepatology
At the beginning of April 2022 10 cases of severe acute hepatitis of unknown origin in children <...
Public health
Hepatitis E in India
The study of hepatitis E is deeply intertwined with India. The existence of hepatitis E virus as a d...
Call for HEV abstract submission
Prof. Philip Meuleman, together with Prof. Heiner Wedemeyer and a few other colleagues, is organizin...
About us
MISSION & VALUES
Global Hepatitis E Platform
The mission of the Global Hepatitis E Platform is to enhance the global awareness and knowledge about hepatitis E. We connect all stakeholders to join forces for advancing hepatitis E research, education, public health and patient care.
We promote transparency, objectivity and collaboration in pursuit of knowledge and insights, wherever this may lead us.
MANAGEMENT TEAM
EVENTS
2022-08-30
PhD defence ceremony of Y. Li on hepatitis E therapeutic development
You are hereby invited to the PhD defence ceremony of Y. Li on Tuesday, 30 August 2022 at 15.30 hrs (Central European Time); Title thesis: Drug Repurposing for Treating Hepatitis E Virus Infection; Promotor(s): Prof. dr. M.P. Peppelenbosch; Prof. R.A. de Man; Copromotor: Dr. Q. Pan; Link to the live stream of the PhD defense ceremony: https://youtu.be/6A_vGkLuOuE
You are hereby invited to the PhD defence ceremony of Y. Li on Tuesday, 30 August 2022 at 15.30 hrs (Central European Time); Title thesis: Drug Repurposing for Treating Hepatitis E Virus Infection; Promotor(s): Prof. dr. M.P. Peppelenbosch; Prof. R.A. de Man; Copromotor: Dr. Q. Pan; Link to the live stream of the PhD defense ceremony: https://youtu.be/6A_vGkLuOuE
